Clinical Trial Update: Use of Risperidone in ECT for Treatment Resistant Depression [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating risperidone augmentation with electroconvulsive therapy for treatment-resistant depression was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Major Depression | Phase 4 | Status: TERMINATED